Reproductive technology and postmenopausal motherhood.
作者信息
Kluge E H
机构信息
Department of Philosophy, University of Victoria.
出版信息
CMAJ. 1994 Aug 1;151(3):353, 355.
Abstract
摘要
相似文献
1
Reproductive technology and postmenopausal motherhood.生殖技术与绝经后母亲身份
CMAJ. 1994 Aug 1;151(3):353, 355.
2
A closer look at reproductive technology and postmenopausal motherhood.深入探讨生殖技术与绝经后母亲身份
CMAJ. 1996 Apr 15;154(8):1189-91.
3
Postmenopausal motherhood: immoral, illegal? A case study.绝经后生育：不道德、违法？一项案例研究。
Bioethics. 2007 Oct;21(8):458-63. doi: 10.1111/j.1467-8519.2007.00583.x.
4
[The irrepressible laugh].[抑制不住的笑声]。
Contracept Fertil Sex. 1994 May;22(5):310-1.
5
Oocyte donation to postmenopausal women.向绝经后妇女捐赠卵母细胞。
Fertil Steril. 2004 Sep;82 Suppl 1:S254-5. doi: 10.1016/j.fertnstert.2004.05.027.
6
[Pregnancy in the elderly woman].[老年女性怀孕]
Contracept Fertil Sex. 1993 Nov;21(11):848.
7
Too old at 59?
Nature. 1994 Jan 6;367(6458):2. doi: 10.1038/367002a0.
8
Pregnancies are acceptable in post-menopausal women.
Hum Reprod. 1993 Oct;8(10):1542-4. doi: 10.1093/oxfordjournals.humrep.a137887.
9
[Aged mothers; fear of finality determines medical action].[高龄母亲；对结局的恐惧决定医疗行为]
Ned Tijdschr Geneeskd. 1994 Jun 11;138(24):1247.
10
Pregnancy after the menopause: a challenge to nature?
Hum Reprod. 1993 Sep;8(9):1344-5. doi: 10.1093/oxfordjournals.humrep.a138257.
引用本文的文献
1
Advanced maternal age: ethical and medical considerations for assisted reproductive technology.高龄产妇：辅助生殖技术的伦理与医学考量
Int J Womens Health. 2017 Aug 16;9:561-570. doi: 10.2147/IJWH.S139578. eCollection 2017.
本文引用的文献
1
Studies on coumarin anticoagulant drugs. Initiation of warfarin therapy without a loading dose.香豆素类抗凝药物的研究。不采用负荷剂量起始华法林治疗。
Circulation. 1968 Jul;38(1):169-77. doi: 10.1161/01.cir.38.1.169.
2
Anticoagulation in patients with atrial fibrillation. Atrial fibrillation associated with aging.心房颤动患者的抗凝治疗。心房颤动与衰老相关。
BMJ. 1993 Dec 4;307(6917):1494. doi: 10.1136/bmj.307.6917.1494-a.
3
Laboratory control of anticoagulant therapy.抗凝治疗的实验室监测
Semin Thromb Hemost. 1986 Jan;12(1):13-9. doi: 10.1055/s-2007-1003531.
4
Atrial fibrillation: a major contributor to stroke in the elderly. The Framingham Study.心房颤动：老年人中风的主要诱因。弗雷明汉姆研究。
Arch Intern Med. 1987 Sep;147(9):1561-4.
5
Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK study.华法林与阿司匹林预防慢性心房颤动血栓栓塞并发症的安慰剂对照随机试验。哥本哈根AFASAK研究。
Lancet. 1989 Jan 28;1(8631):175-9. doi: 10.1016/s0140-6736(89)91200-2.
6
Canadian Atrial Fibrillation Anticoagulation (CAFA) Study.加拿大房颤抗凝（CAFA）研究
J Am Coll Cardiol. 1991 Aug;18(2):349-55. doi: 10.1016/0735-1097(91)90585-w.
7
Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation. Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Investigators.华法林用于预防非风湿性心房颤动相关的中风。退伍军人事务部非风湿性心房颤动中风预防研究人员。
N Engl J Med. 1992 Nov 12;327(20):1406-12. doi: 10.1056/NEJM199211123272002.
8
Rules of evidence and clinical recommendations on the use of antithrombotic agents.抗血栓药物使用的证据规则及临床建议。
Chest. 1992 Oct;102(4 Suppl):305S-311S.
9
Oral anticoagulants. Mechanism of action, clinical effectiveness, and optimal therapeutic range.口服抗凝剂。作用机制、临床疗效及最佳治疗范围。
Chest. 1992 Oct;102(4 Suppl):312S-326S. doi: 10.1378/chest.102.4.312s.
Zotero 插件